An immunoinformatic approach for developing a multi-epitope subunit vaccine against Monkeypox virus

Area of Science:

• * Bioinformatics and Vaccinology
• * Computational Biology
• * Virology

Background:

• * The Monkeypox virus outbreak necessitates rapid development of effective vaccines.
• * Traditional vaccine development is time-consuming and resource-intensive.
• * In-silico approaches offer a faster, cost-effective alternative for vaccine design.

Purpose of the Study:

• * To design and computationally validate a multi-epitope subunit vaccine against Monkeypox virus.
• * To predict the immunogenicity, allergenicity, and structural stability of the vaccine construct.
• * To assess the interaction of the vaccine with the Toll-like receptor 4 (TLR4) for immune activation.

Main Methods:

• * Selection of T-cell and B-cell epitopes from Monkeypox viral proteins.
• * In-silico analysis of antigenicity, allergenicity, and physicochemical properties.
• * Prediction of secondary and 3D structures using SOPMA and I-TASSER.
• * Molecular docking and dynamics simulations to assess vaccine-receptor interactions.
• * Computational immune response prediction.

Main Results:

• * A multi-epitope vaccine construct was successfully designed.
• * The construct exhibited favorable physicochemical properties and low allergenicity.
• * Molecular docking and dynamics simulations confirmed stable interaction with TLR4.
• * Computational immune assays predicted a robust immune response against Monkeypox.

Conclusions:

• * The developed in-silico multi-epitope vaccine construct is a potent candidate against Monkeypox.
• * Computational methods provide a viable strategy for rapid vaccine development.
• * Further experimental validation is warranted to confirm efficacy.